The Scientific Advisors at Olatec Therapeutics are tasked with providing expert guidance on the design, development, and implementation of research projects related to NLRP3 antagonist therapeutics. They leverage their extensive knowledge in immunology and pharmacology to help shape clinical strategies, support regulatory submissions, and ensure that the scientific integrity of the company's therapeutic innovations is maintained. By collaborating with cross-functional teams, they aim to advance Olatec’s mission of addressing a wide range of inflammatory diseases.
Alberto Mantovani
Scientific Advisor
Antonio Abbate
Scientific Advisor
Howard I. Maibach
Scientific Advisor
Leo A. B. Joosten
Scientific Advisor
Peter Libby
Scientific Advisor
Robert H. Dworkin
Scientific Advisor
Robert M. Fielding
Scientific Advisor
Shayne C. Gad
Scientific Advisor
Viola T. Kung
Scientific Advisor
William J. Cunningha...
Scientific Advisor
View all